Megan Lynn Krajewski, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Echocardiography, Transesophageal | 2 | 2022 | 1093 | 0.440 |
Why?
|
| Mitral Valve | 1 | 2019 | 1475 | 0.350 |
Why?
|
| Calcinosis | 1 | 2019 | 1478 | 0.340 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2019 | 1564 | 0.300 |
Why?
|
| Nitric Oxide Donors | 1 | 2008 | 122 | 0.300 |
Why?
|
| Anemia, Sickle Cell | 3 | 2013 | 1062 | 0.280 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2022 | 1480 | 0.270 |
Why?
|
| Cardiomyopathies | 1 | 2019 | 2066 | 0.260 |
Why?
|
| Intraoperative Care | 2 | 2019 | 763 | 0.240 |
Why?
|
| Arginine | 1 | 2008 | 933 | 0.230 |
Why?
|
| Vasodilator Agents | 1 | 2008 | 988 | 0.220 |
Why?
|
| Nitric Oxide | 2 | 2012 | 2143 | 0.210 |
Why?
|
| Hemoglobins | 1 | 2008 | 1529 | 0.190 |
Why?
|
| Anesthesia | 2 | 2022 | 1581 | 0.160 |
Why?
|
| Respiration, Artificial | 2 | 2020 | 2711 | 0.150 |
Why?
|
| Thoracic Surgery | 1 | 2022 | 727 | 0.120 |
Why?
|
| Thermosensing | 1 | 2015 | 56 | 0.120 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2020 | 1166 | 0.120 |
Why?
|
| Quadriplegia | 1 | 2015 | 227 | 0.110 |
Why?
|
| Anesthetics | 1 | 2018 | 524 | 0.100 |
Why?
|
| Niacin | 1 | 2013 | 116 | 0.100 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2012 | 116 | 0.100 |
Why?
|
| Respiration | 1 | 2018 | 1652 | 0.100 |
Why?
|
| Respiratory Insufficiency | 1 | 2020 | 1241 | 0.090 |
Why?
|
| Thrombolytic Therapy | 1 | 2020 | 2059 | 0.090 |
Why?
|
| Cold Temperature | 1 | 2015 | 794 | 0.090 |
Why?
|
| Intubation, Intratracheal | 1 | 2018 | 1303 | 0.090 |
Why?
|
| Nitric Oxide Synthase | 2 | 2012 | 911 | 0.080 |
Why?
|
| Vasodilation | 1 | 2013 | 970 | 0.080 |
Why?
|
| Heart Diseases | 1 | 2022 | 2818 | 0.080 |
Why?
|
| Critical Illness | 1 | 2020 | 2745 | 0.070 |
Why?
|
| Cholesterol, HDL | 1 | 2013 | 1811 | 0.070 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2022 | 3673 | 0.070 |
Why?
|
| Hemolysis | 1 | 2008 | 407 | 0.060 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2018 | 1899 | 0.060 |
Why?
|
| Purine Nucleosides | 1 | 2004 | 30 | 0.060 |
Why?
|
| Dioxolanes | 1 | 2004 | 23 | 0.060 |
Why?
|
| Guanosine | 1 | 2004 | 43 | 0.060 |
Why?
|
| Endothelium, Vascular | 2 | 2013 | 4422 | 0.060 |
Why?
|
| Guanosine Triphosphate | 1 | 2004 | 313 | 0.060 |
Why?
|
| Tyrosine | 1 | 2008 | 1427 | 0.050 |
Why?
|
| Phosphotransferases | 1 | 2004 | 302 | 0.050 |
Why?
|
| Microcirculation | 1 | 2008 | 1279 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3099 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3222 | 0.050 |
Why?
|
| Lipids | 1 | 2013 | 3316 | 0.050 |
Why?
|
| Internship and Residency | 1 | 2022 | 5944 | 0.050 |
Why?
|
| Lung | 1 | 2018 | 10031 | 0.040 |
Why?
|
| Hemodynamics | 1 | 2008 | 4188 | 0.040 |
Why?
|
| Cognition | 1 | 2015 | 7045 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2008 | 3139 | 0.030 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2022 | 1090 | 0.030 |
Why?
|
| Humans | 12 | 2022 | 765823 | 0.030 |
Why?
|
| omega-N-Methylarginine | 1 | 2012 | 108 | 0.030 |
Why?
|
| Skin Temperature | 1 | 2012 | 96 | 0.020 |
Why?
|
| Aged | 3 | 2020 | 171178 | 0.020 |
Why?
|
| Male | 6 | 2021 | 363740 | 0.020 |
Why?
|
| Fibrinolytic Agents | 1 | 2020 | 2082 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2013 | 10723 | 0.020 |
Why?
|
| Acetylcholine | 1 | 2012 | 626 | 0.020 |
Why?
|
| Oxygen | 1 | 2022 | 4242 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 2013 | 967 | 0.020 |
Why?
|
| Adult | 6 | 2022 | 223055 | 0.020 |
Why?
|
| Hypolipidemic Agents | 1 | 2013 | 608 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 18289 | 0.020 |
Why?
|
| Consensus | 1 | 2018 | 3199 | 0.020 |
Why?
|
| Curriculum | 1 | 2022 | 3780 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2012 | 1382 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2022 | 5338 | 0.020 |
Why?
|
| Anesthesiology | 1 | 2018 | 1122 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2021 | 65223 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2018 | 3686 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2022 | 54798 | 0.010 |
Why?
|
| Middle Aged | 4 | 2021 | 223016 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2012 | 6320 | 0.010 |
Why?
|
| Analgesics, Opioid | 1 | 2018 | 3834 | 0.010 |
Why?
|
| Prevalence | 1 | 2018 | 15832 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8698 | 0.010 |
Why?
|
| Risk | 1 | 2012 | 9600 | 0.010 |
Why?
|
| Echocardiography | 1 | 2012 | 5042 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2013 | 12421 | 0.010 |
Why?
|
| Female | 4 | 2021 | 396050 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 41643 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2018 | 24278 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2004 | 6110 | 0.010 |
Why?
|
| Animals | 1 | 2008 | 168730 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2018 | 15794 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2022 | 81505 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2004 | 8278 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2004 | 3051 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 39226 | 0.010 |
Why?
|
| Risk Factors | 1 | 2018 | 74853 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 59849 | 0.000 |
Why?
|
| Adolescent | 1 | 2013 | 88794 | 0.000 |
Why?
|